These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 16273017)

  • 21. Use of neurotransmitter regulators in functional gastrointestinal disorders based on symptom analysis.
    Luo QQ; Chen SL
    J Dig Dis; 2017 Apr; 18(4):203-206. PubMed ID: 28371414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antidepressants for neuropathic pain: a Cochrane review.
    Saarto T; Wiffen PJ
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1372-3. PubMed ID: 20543189
    [No Abstract]   [Full Text] [Related]  

  • 23. [Functional and motor gastrointestinal disorders].
    Mearin F; Rey E; Balboa A
    Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():3-12. PubMed ID: 26520191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New antidepressants in the treatment of neuropathic pain. A review.
    Mattia C; Paoletti F; Coluzzi F; Boanelli A
    Minerva Anestesiol; 2002 Mar; 68(3):105-14. PubMed ID: 11981519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Withdrawal symptoms of antidepressants].
    Vlaminck JJ; van Vliet IM; Zitman FG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(13):698-701. PubMed ID: 15819135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mirtazapine versus other antidepressive agents for depression].
    Knud Larsen J
    Ugeskr Laeger; 2012 Nov; 174(46):2864-6. PubMed ID: 23153468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment considerations for patients with neuropathic pain and other medical comorbidities.
    Haanpää ML; Gourlay GK; Kent JL; Miaskowski C; Raja SN; Schmader KE; Wells CD
    Mayo Clin Proc; 2010 Mar; 85(3 Suppl):S15-25. PubMed ID: 20194144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug therapy for irritable bowel syndrome. What works, what doesn't work and for whom?].
    Mönnikes H; Schmidtmann M; van der Voort IR
    Internist (Berl); 2006 Oct; 47(10):1073-6, 1078-83. PubMed ID: 16988806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidepressants in IBS: are we deluding ourselves?
    Talley NJ
    Am J Gastroenterol; 2004 May; 99(5):921-3. PubMed ID: 15128361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tests to detect GI motility disorders and GI sensation in irritable bowel syndrome].
    Okumura T
    Nihon Rinsho; 2006 Aug; 64(8):1457-60. PubMed ID: 16898612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases.
    Grover M; Camilleri M
    J Gastroenterol; 2013 Feb; 48(2):177-81. PubMed ID: 23254779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrally acting therapies for irritable bowel syndrome.
    Grover M; Drossman DA
    Gastroenterol Clin North Am; 2011 Mar; 40(1):183-206. PubMed ID: 21333907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
    Madisch A; Vinson BR; Abdel-Aziz H; Kelber O; Nieber K; Kraft K; Storr M
    Wien Med Wochenschr; 2017 May; 167(7-8):160-168. PubMed ID: 28424994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology.
    Lebel AA
    J Pediatr Gastroenterol Nutr; 2008 Nov; 47(5):703-5. PubMed ID: 18955884
    [No Abstract]   [Full Text] [Related]  

  • 38. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease.
    Mayer EA; Tillisch K; Bradesi S
    Aliment Pharmacol Ther; 2006 Sep; 24(6):919-33. PubMed ID: 16948804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary.
    Williams JW; Mulrow CD; Chiquette E; Noël PH; Aguilar C; Cornell J
    Ann Intern Med; 2000 May; 132(9):743-56. PubMed ID: 10787370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.